RGLD · Royal Gold Inc · Insider Trading

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $231.39 to $231.79, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $233.72 to $234.68, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $235.84 to $235.98, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $234.72 to $235.47, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $230.18 to $230.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $232.72 to $233.70, inclusive.

Represents shares withheld to satisfy taxes; no shares were sold.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $261.91 to $262.72, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $264.02 to $264.89, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $260.72 to $261.61, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $263.02 to $264.01, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $259.69 to $260.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on December 3, 2025 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $279.94 to $280.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on December 3, 2025 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $280.95 to $281.74, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on December 3, 2025 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $283.38 to $284.05, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on December 3, 2025 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on December 3, 2025 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $282.32 to $283.25, inclusive.

The reporting person's sales reported in this Form 4 were effected pursuant to a written plan adopted by the reporting person on December 3, 2025 in accordance with Rule 10b5-1(c) of the Securities Exchange Act of 1934.

The price reported above reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $285.75 to $286.68, inclusive.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Represents shares withheld to satisfy taxes; no shares were sold.

Grant of restricted stock units vesting one-half on the first anniversary of the grant date and one-half on the third anniversary of the grant date.

Each share of phantom stock is the economic equivalent of one share of common stock.

Grant of restricted stock vesting one-third annually over three years beginning on the first anniversary of the grant date.

Grant of restricted stock units vesting one-third annually over three years beginning on the first anniversary of the grant date.

Each share of phantom stock is the economic equivalent of one share of common stock.

Grant of restricted stock vesting one-third annually over three years beginning on the first anniversary of the grant date.

Grant of restricted stock vesting one-half on the first anniversary of the grant date and one-half on the third anniversary of the grant date.

Each share of phantom stock is the economic equivalent of one share of common stock.

Grant of restricted stock vesting one-half on the first anniversary of the grant date and one-half on the third anniversary of the grant date.

Grant of restricted stock vesting one-third annually over three years beginning on the first anniversary of the grant date.